Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1757-2215
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Establishment and validation of an RNA binding protein-associated prognostic model for ovarian cancer ; volume:14 ; number:1 ; day:7 ; month:2 ; year:2021 ; pages:1-11 ; date:12.2021
Journal of ovarian research ; 14, Heft 1 (7.2.2021), 1-11, 12.2021
- Urheber
-
He, Chaofan
Huang, Fuxin
Zhang, Kejia
Wei, Jun
Hu, Ke
Liang, Meng
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13048-021-00777-1
- URN
-
urn:nbn:de:101:1-2021032921292555411201
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- He, Chaofan
- Huang, Fuxin
- Zhang, Kejia
- Wei, Jun
- Hu, Ke
- Liang, Meng
- SpringerLink (Online service)
Ähnliche Objekte (12)
Establishment and validation of an immune infiltration predictive model for ovarian cancer
Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma
Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer
Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value
Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas
Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma
Establishment and validation of a prognostic nomogram for patients with early-onset stage I–II colon cancer
Establishment and validation of an immune infiltration predictive model for ovarian cancer
Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma
Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer
Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value
Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas
Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma
Establishment and validation of a prognostic nomogram for patients with early-onset stage I–II colon cancer
Establishment and validation of an immune infiltration predictive model for ovarian cancer
Establishment and validation of a novel prognostic model for non-virus-related hepatocellular carcinoma
External validation suggests Integrin beta 3 as prognostic biomarker in serous ovarian adenocarcinomas
Construction and validation of a transcription factors-based prognostic signature for ovarian cancer
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma
Establishment and validation of a novel invasion-related gene signature for predicting the prognosis of ovarian cancer
Identification and validation of IRF6 related to ovarian cancer and biological function and prognostic value
Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas
Development and validation of an RNA binding protein-associated prognostic model for hepatocellular carcinoma
Establishment and validation of a novel peroxisome-related gene prognostic risk model in kidney clear cell carcinoma